Excalibur Management Corp Abb Vie Inc. Transaction History

Excalibur Management Corp

$261 Million
Q3 2024

A detailed history of Excalibur Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Excalibur Management Corp holds 13,852 shares of ABBV stock, worth $2.48 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

13,852

Previous 14,057 1.46%

Holding current value

$2.48 Million

Previous $2.41 Million 13.44%

% of portfolio

1.05%

Previous 0.99%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $33,587 - $40,862	-205 Reduced 1.46%	13,852 $2.74 Million
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $23,992 - $28,017	155 Added 1.11%	14,057 $2.41 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $15,502 - $17,663	-97 Reduced 0.69%	13,902 $2.53 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $825 - $929	-6 Reduced 0.04%	13,999 $2.17 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $25,649 - $29,692	192 Added 1.39%	14,005 $2.09 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $8,745 - $10,883	66 Added 0.48%	13,813 $1.86 Million
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $19,377 - $22,316	-134 Reduced 0.97%	13,747 $2.19 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $13,277 - $15,923	-96 Reduced 0.69%	13,881 $2.24 Million
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $3,355 - $3,848	25 Added 0.18%	13,977 $1.88 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $303,452 - $385,786	-2,205 Reduced 13.65%	13,952 $2.14 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $105,056 - $130,345	796 Added 5.18%	16,157 $2.62 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $32,443 - $41,050	302 Added 2.01%	15,361 $2.08 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $10,852 - $12,319	102 Added 0.68%	15,059 $1.62 Million
Q2 2021 Jul 26, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 0.66%	14,957 $1.69 Million
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $85,727 - $94,375	838 Added 5.89%	15,057 $1.63 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $317,211 - $428,268	3,941 Added 38.34%	14,219 $1.52 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $3,436 - $4,033	40 Added 0.39%	10,278 $900,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $86,136 - $115,263	1,174 Added 12.95%	10,238 $1.01 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $542,574 - $822,609	-8,412 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $416,190 - $520,742	5,770 Added 218.4%	8,412 $745,000
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $166,393 - $200,052	2,642 New	2,642 $200,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.

Account

Excalibur Management Corp Abb Vie Inc. Transaction History